The genetic variability of HIV-1 and its implications.
Peeters
M
M
UR36, Laboratoire Retrovirus, IRD, Montpellier, France. martine.peeters@mpl.ird.fr
D015492:AIDS Serodiagnosis; D016915:AIDS Vaccines; D000818:Animals; D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use; D018450:Disease Progression; D004352:Drug Resistance, Microbial / Q000235:genetics; D014644:Genetic Variation; D016679:Genome, Viral; D014943:Global Health; D015488:HIV Antigens / Q000235:genetics / Q000276:immunology; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000635:transmission / Q000821:virology; D015497:HIV-1 / Q000145:classification / Q000187:drug effects / Q000235:genetics* / Q000276:immunology / Q000472:pathogenicity; D015498:HIV-2 / Q000472:pathogenicity; D006801:Humans; D008251:Macaca / Q000821:virology; D002679:Pan troglodytes / Q000821:virology; D011995:Recombination, Genetic; D015163:Superinfection
D016915:AIDS Vaccines; D019380:Anti-HIV Agents; D015488:HIV Antigens